Improved tumor contrast achieved by single time point dual-reporter fluorescence imaging

Journal of Biomedical Optics

Volumn 17, Issue 6, 2012, Pages

  Tichauer, Kenneth M ^a   Samkoe, Kimberley S ^a,b   Sexton, Kristian J ^a   Gunn, Jason R ^a   Hasan, Tayyaba ^c   Pogue, Brian W ^a,b,c  

^a DARTMOUTH COLLEGE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Binding potential; Cancer; Epidermal growth factor receptor; Fluorescence; Molecular imaging; Receptor; Xenograft

Indexed keywords

COLLAGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; LAMININ; MATRIGEL; PROTEOGLYCAN;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CHEMICAL MODEL; CHEMISTRY; DRUG COMBINATION; FLUORESCENCE MICROSCOPY; HEMODYNAMICS; HUMAN; IMAGE PROCESSING; METABOLISM; METHODOLOGY; MOUSE; NEOPLASM; PATHOLOGY; RAT; RECEIVER OPERATING CHARACTERISTIC; REPORTER GENE; TIME; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; COLLAGEN; DRUG COMBINATIONS; GENES, REPORTER; HEMODYNAMICS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LAMININ; MICE; MICROSCOPY, FLUORESCENCE; MODELS, CHEMICAL; NEOPLASM TRANSPLANTATION; NEOPLASMS; PROTEOGLYCANS; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; ROC CURVE; TIME FACTORS;

EID: 84868648806     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.17.6.066001     Document Type: Article

References (42)

1. S. Gioux, H. S. Choi, and J. V. Frangioni, "Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation," Mol. Imag. 9(5), 237-255 (2010).
2. B. W. Pogue et al., "Review of neurosurgical fluorescence imaging methodologies (vol. 16, pg 493, 2010)," IEEE J. Sel. Top. Quant. 16(6), 1847-1847 (2010).
3. D. W. Roberts et al., "Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between delta-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters," J. Neurosurg. 114(3), 595-603 (2011).
4. W. Stummer et al., "Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial," Lancet Oncol. 7(5), 392-401 (2006).
5. S. L. Troyan et al., "The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping," Ann. Surg. Oncol. 16(10), 2943-2952 (2009).
6. G. M. van Dam et al., "Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first inhuman results," Nat. Med. 17, 1315-1319 (2011).
7. N. Kosaka et al., "Near infrared fluorescence-guided real-time endoscopic detection of peritoneal ovarian cancer nodules using intravenously injected indocyanine green," Int. J. Cancer 129(7), 1671-1677 (2011).
8. E. M. Sevick-Muraca et al., "Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study," Radiology 246(3), 734-741 (2008).
9. N. Tagaya et al., "Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer," Am. J. Surg. 195(6), 850-853 (2008). (Pubitemid 351749448)
10. R. Weissleder and M. J. Pittet, "Imaging in the era of molecular oncology," Nature 452(7187), 580-589 (2008). (Pubitemid 351483372)
11. H. Maeda et al., "Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review," J. Control. Release 65(1-2), 271-284 (2000). (Pubitemid 30122932)
12. R. K. Jain, "Transport of molecules, particles, and cells in solid tumors," Annu. Rev. Biomed. Eng. 1, 241-263 (1999). (Pubitemid 129740012)
13. J. W. Baish et al., "Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model," Microvasc. Res. 51(3), 327-346 (1996). (Pubitemid 26162001)
14. G. Lappin, "Microdosing: current and the future," Bioanalysis 2(3), 509-517 (2010).
15. V. Ntziachristos et al., "Fluorescence molecular tomography resolves protease activity in vivo," Nat. Med. 8(7), 757-760 (2002). (Pubitemid 34778731)
16. R. Weissleder et al., "In vivo imaging of tumors with protease-activated near-infrared fluorescent probes," Nat. Biotechnol. 17(4), 375-378 (1999). (Pubitemid 29166041)
17. D. M. Goldenberg et al., "Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen," Cancer Res. 40(8 Pt. 2), 2984-2992 (1980).
18. K. R. Hine et al., "Radioimmunodetection of gastrointestinal neoplasms with antibodies to carcinoembryonic antigen," Cancer Res. 40(8 Pt. 2), 2993-2996 (1980).
19. J. T. Liu et al., "Quantifying cell-surface biomarker expression in thick tissues with ratiometric three-dimensional microscopy," Biophys. J. 96(6), 2405-2414 (2009).
20. B. W. Pogue et al., "Imaging targeted-agent binding in vivo with two probes," J. Biomed. Opt. 15(3), 030513 (2010).
21. K. M. Tichauer et al., "In vivo quantification of tumor receptor binding potential with dual-reporter molecular imaging," Mol. Imag. Biol. (2011).
22. A. A. Lammertsma and S. P. Hume, "Simplified reference tissue model for PET receptor studies," Neuroimage 4(3 Pt. 1), 153-158 (1996).
23. J. Logan et al., "Distribution volume ratios without blood sampling from graphical analysis of PET data," J. Cereb. Blood Flow Metab. 16(5), 834-840 (1996). (Pubitemid 26292051)
24. C. T. Kuan, C. J. Wikstrand, and D. D. Bigner, "EGF mutant receptor vIII as a molecular target in cancer therapy," Endocr. Relat. Cancer 8(2), 83-96 (2001). (Pubitemid 32641351)
25. J. Delforge et al., "In vivo quantification and parametric images of the cardiac beta-adrenergic receptor density," J. Nucl. Med. 43(2), 215-226 (2002). (Pubitemid 34151046)
26. K. S. Samkoe et al., "High vascular delivery of EGF, but low receptor binding rate is observed in AsPC-1 tumors as compared to normal pancreas," Mol. Imag. Biol. Aug. 17, [Epub ahead of print] (2011).
27. R. B. Innis et al., "Consensus nomenclature for in vivo imaging of reversibly binding radioligands," J. Cereb. Blood Flow Metab. 27(9), 1533-1539 (2007). (Pubitemid 47301451)
28. S. L. Gibbs-Strauss et al., "Detecting epidermal growth factor receptor tumor activity in vivo during cetuximab therapy of murine gliomas," Acad. Radiol. 17(1), 7-17 (2010).
29. J. J. Smith, R. Derynck, and M. Korc, "Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle," Proc. Natl. Acad. Sci. USA 84(21), 7567-7570 (1987).
30. C. J. Wikstrand et al., "Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII," Cancer Res. 57(18), 4130-4140 (1997). (Pubitemid 27427708)
31. J. L. Kovar et al., "A systematic approach to the development agents for optical imaging of mouse of fluorescent contrast cancer models," Anal. Biochem. 367(1), 1-12 (2007). (Pubitemid 46938663)
32. J. L. Kovar et al., "A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models," Anal. Biochem. 367(1), 1-12 (2007). (Pubitemid 46938663)
33. A. I. Minchinton and I. F. Tannock, "Drug penetration in solid tumours," Nat. Rev. Cancer 6(8), 583-592 (2006). (Pubitemid 44140857)
34. J. K. Willmann et al., "Molecular imaging in drug development," Nat. Rev. Drug Discov. 7(7), 591-607 (2008). (Pubitemid 351927724)
35. T. Olafsen and A. M.Wu, "Antibody vectors for imaging," Semin. Nucl. Med. 40(3), 167-181 (2010).
36. H. S. Choi et al., "Renal clearance of quantum dots," Nat. Biotechnol. 25(10), 1165-1170 (2007).
37. M. W. Dewhirst et al., "Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature," Int. J. Radiat. Oncol. Biol. Phys. 17(1), 91-99 (1989). (Pubitemid 19173243)
38. V. Tolmachev et al., "Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount," Eur. J. Nucl. Med. Mol. Imag. 37(3), 613-622 (2010).
39. S. B. Lee et al., "Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging," Clin. Canc. Res. 14(12), 3840-3849 (2008).
40. V. Chernomordik et al., "Quantitative analysis of Her2 receptor expression in vivo by near-infrared optical imaging," Mol. Imag. 9(4), 192-200 (2010).
41. M. Korc et al., "Binding of epidermal growth factor in rat pancreatic acini," Biochem. Biophys. Res. Commun. 111(3), 1066-1073 (1983). (Pubitemid 13081854)
42. M. Hassan et al., "In vivo method to monitor changes in HER2 expression using near-infrared fluorescence imaging," Mol. Imag., Sep 30, [Epub ahead of print] (2011).